
The Library
Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC) : can this lead to the adverse effect of hypogonadism?
Tools
Afshar, Mehran, Patel, Hiten R. H., Jain, Ankit, Kumar, Abhishek, Patel, Prashant, James, Nicholas D. and Porfiri, Emilio (2019) Chronic tyrosine kinase inhibitor (TKI) use in metastatic renal cell carcinoma (mRCC) : can this lead to the adverse effect of hypogonadism? Expert Review of Anticancer Therapy, 19 (6). pp. 529-532. doi:10.1080/14737140.2019.1609355 ISSN 1473-7140.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: http://dx.doi.org/10.1080/14737140.2019.1609355
Item Type: | Journal Article | ||||||
---|---|---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Research Centres > Warwick Systems Biology Centre Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
||||||
Journal or Publication Title: | Expert Review of Anticancer Therapy | ||||||
ISSN: | 1473-7140 | ||||||
Official Date: | 2 May 2019 | ||||||
Dates: |
|
||||||
Volume: | 19 | ||||||
Number: | 6 | ||||||
Page Range: | pp. 529-532 | ||||||
DOI: | 10.1080/14737140.2019.1609355 | ||||||
Status: | Peer Reviewed | ||||||
Publication Status: | Published | ||||||
Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
![]() |
View Item |